Semaglutide works by mimicking the action of the GLP-1 hormone, which regulates appetite and food intake
Not sure which brands are reputable
the applicable beyond-use period is defined by the licensed product's SmPC and local pharmacy policy
India GLP-1 Receptor Agonist Market Analysis The India GLP-1 receptor agonist market was valued at USD 1.20 billion in 2025, fueled by expanding contract peptide manufacturing ecosystem, increasing participation of domestic pharmaceutical companies in GLP-1 biosimilar and novel peptide development, and rising availability of specialized diabetes clinics in urban centers
Pathway One: GHRH Analogs (CJC-1295, Sermorelin, Tesamorelin) These compounds mimic growth hormone-releasing hormone (GHRH), the signal from the hypothalamus that tells the pituitary to manufacture and release GH
Ohtani Y, Matsuda I: Valproate treatment and carnitine deficiency